tiprankstipranks
Advertisement
Advertisement

DE:IDP Stock Latest News

Needham upgrades Biogen on pipeline potential, stabilizing core business
The FlyNeedham upgrades Biogen on pipeline potential, stabilizing core business
2d ago
BIIB
Biogen upgraded to Buy from Hold at Needham
PremiumThe Fly
Biogen upgraded to Buy from Hold at Needham
2d ago
BIIB
Biogen granted Breakthrough Therapy Designation for salanersen by FDA
PremiumThe Fly
Biogen granted Breakthrough Therapy Designation for salanersen by FDA
6d ago
BIIB
UCB, Biogen announce dapirolizumab pegol data at EULAR
PremiumThe Fly
UCB, Biogen announce dapirolizumab pegol data at EULAR
6d ago
BIIB
Biogen, UCB publishes full results from PHOENYCS GO clinical trial in The Lancet
PremiumThe Fly
Biogen, UCB publishes full results from PHOENYCS GO clinical trial in The Lancet
9d ago
BIIB
Biogen price target raised to $227 from $222 at RBC Capital
PremiumThe FlyBiogen price target raised to $227 from $222 at RBC Capital
14d ago
BIIB
Biogen and Denali’s Parkinson’s candidate did not meet Phase 2b endpoints
Premium
The Fly
Biogen and Denali’s Parkinson’s candidate did not meet Phase 2b endpoints
20d ago
BIIB
DNLI
Biogen Earnings Call Signals Confident, Investment-Heavy Transition
Premium
Company Announcements
Biogen Earnings Call Signals Confident, Investment-Heavy Transition
22d ago
BIIB
Immunic appoints Michael Bonney as chair
PremiumThe Fly
Immunic appoints Michael Bonney as chair
22d ago
BIIB
IMUX
Goldman’s Richter Reiterates Buy on Biogen as Leqembi Outperforms and Price Target Rises from $238 to $250
PremiumRatings
Goldman’s Richter Reiterates Buy on Biogen as Leqembi Outperforms and Price Target Rises from $238 to $250
26d ago
BIIB
Biogen: Hold Rating Reiterated as Pipeline Concerns Offset Leqembi Growth; $196 Price Target Maintained
PremiumRatings
Biogen: Hold Rating Reiterated as Pipeline Concerns Offset Leqembi Growth; $196 Price Target Maintained
26d ago
BIIB
Cisco upgraded, Doximity downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Cisco upgraded, Doximity downgraded: Wall Street’s top analyst calls
26d ago
AOS
PHR
Biogen resumed with an Outperform at Evercore ISI
PremiumThe FlyBiogen resumed with an Outperform at Evercore ISI
26d ago
BIIB
Biogen price target raised to $225 from $214 at Piper Sandler
Premium
The Fly
Biogen price target raised to $225 from $214 at Piper Sandler
26d ago
BIIB
Hold Rating Maintained on Biogen as BIIB080 Moves to Phase 3; Risk-Reward Seen Balanced with Unchanged $206 Price Target
Premium
Ratings
Hold Rating Maintained on Biogen as BIIB080 Moves to Phase 3; Risk-Reward Seen Balanced with Unchanged $206 Price Target
26d ago
BIIB
Biogen Buy Rating Reiterated as Tau Data Eases Overhang; Price Target Maintained at $225
PremiumRatings
Biogen Buy Rating Reiterated as Tau Data Eases Overhang; Price Target Maintained at $225
26d ago
BIIB
Biogen Rated Hold as Analyst Cites Mixed Alzheimer’s Data and Commercial Hurdles; $203 Price Target Reiterated
PremiumRatings
Biogen Rated Hold as Analyst Cites Mixed Alzheimer’s Data and Commercial Hurdles; $203 Price Target Reiterated
26d ago
BIIB
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
PremiumThe Fly
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
27d ago
DYN
ALEC
Biogen Buy Rating Reiterated as CELIA Phase 2 Diranersen Data De-Risk Tau Strategy and Support Unchanged $237 Price Target
PremiumRatings
Biogen Buy Rating Reiterated as CELIA Phase 2 Diranersen Data De-Risk Tau Strategy and Support Unchanged $237 Price Target
27d ago
BIIB
Minter Reiterates Buy on Biogen as Tau-Targeting Diranersen Data Signals Clinically Meaningful Cognitive Benefit and Strong Biomarker Validation
PremiumRatingsMinter Reiterates Buy on Biogen as Tau-Targeting Diranersen Data Signals Clinically Meaningful Cognitive Benefit and Strong Biomarker Validation
27d ago
BIIB
Video: Cisco surges as AI powers better-than-anticipated forecast
Premium
The Fly
Video: Cisco surges as AI powers better-than-anticipated forecast
27d ago
VIK
BIIB
Biogen completes acquisition of Apellis Pharmaceuticals
Premium
The Fly
Biogen completes acquisition of Apellis Pharmaceuticals
27d ago
APLS
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >